Search Results 1151-1160 of 19863 for Hepatitis+C

1. Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF - Mayo Clinic

   ... c. Claustrophobia: history of severe ... Serologic evidence of Hepatitis B based on hepatitis B surface antigen (HBsAG); e. ... Any over the counter drug, mail ...

2. A Study To Evaluate ALN-6400 In Healthy Volunteers And Patients With Hereditary Hemorrhagic Telangiectasia (HHT) - Mayo Clinic

   ... hepatitis C virus or hepatitis B virus infection * Has an estimated glomerular filtration (eGFR) of \<90 mL/min/1.73m\^2 at screening. Part B: * Has ALT or ...

3. A Study of the Safety and Effectiveness of GS-5745 in Participants with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   HIV, hepatitis B, hepatitis C, or tuberculosis (TB) infection; Participated in a clinical study with an investigational drug or biologic within the last 30 ...

4. A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy - Mayo Clinic

   Positive hepatitis C virus (HCV) antibody at screening. Patients with positive hepatitis C antibody test result with no detectable HCV RNA for at least 12 ...

5. Insulin human regular (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   Sharing needles can result in transmission of hepatitis viruses, HIV, or other bloodborne illnesses. It is very important that your doctor check your ...

6. A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens - Mayo Clinic

   ... hepatitis B virus (HBV) DNA levels . Those who are polymerase chain reaction (PCR) positive will be excluded; or; Known to be seropositive for hepatitis C ...

7. A Study to Compare Durvalumab vs Placebo Following Stereotactic Body Radiation Therapy in Early Stage Non-small Cell Lung Cancer Patients - Mayo Clinic

   ... hepatitis B (known positive hepatitis B surface antigen [HBsAg] result) ... Patients positive for hepatitis C (HCV) antibody are eligible only if ...

8. Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial - Mayo Clinic

   * Known or suspected active hepatitis C infection. * Any medical or psychiatric illness that could, in the investigator's opinion, potentially interfere ...

9. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

   Positive serology for hepatitis C (HC) defined as a positive test for HCAb and confirmed by HC RIBA or hepatitis C virus (HCV) RNA viral load; Screening ...

10. Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202) - Mayo Clinic

    ... Hepatitis C (e.g., Hepatitis C Virus [HCV] RNA [qualitative] is detected). Has known history of Chronic Hepatitis B or C; Has received a live vaccine within ...